Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-19-013620
Filing Date
2019-09-16
Accepted
2019-09-16 14:59:56
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 32018
2 filename2.txt TEXT-EXTRACT 1195
  Complete submission text file 0000000000-19-013620.txt   46013
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filed for) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)